Frederick Brouillette Jr insider trades: King Pharmaceuticals (KG) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Frederick reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 2, 2010 | KG | ↓ Sell | 17,256 | $11.42 | $197K | Direct | Mar 4, 2010 (2d) |
| Nov 16, 2009 | KG | ↓ Sell | 5,533 | $11.50 | $64K | Direct | Nov 17, 2009 (1d) |
| Aug 13, 2009 | KG | ↓ Sell | 5,533 | $10.50 | $58K | Direct | Aug 14, 2009 (1d) |
| Jun 8, 2009 | KG | ↓ Sell | 5,535 | $9.58 | $53K | Direct | Jun 9, 2009 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other KG insiders
Open-market trades in the last 12 months
About Frederick Brouillette Jr's insider trades
Frederick Brouillette Jr is Corporate Compliance Officer at King Pharmaceuticals (KG). Since Jun 8, 2009, Frederick has reported no open-market purchases and 4 sales worth $372K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (14 filings), shares withheld for taxes (6 filings), option exercises (4 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every KG insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.